| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 789 |
| 1 | PREDNISONE | 580 |
| 2 | CAPECITABINE | 486 |
| 3 | METHOTREXATE SODIUM | 451 |
| 4 | OXALIPLATIN | 439 |
| 5 | DEXAMETHASONE | 399 |
| 6 | DEXAMETHASONE 1.5 MG | 399 |
| 7 | METHOTREXATE | 389 |
| 8 | FLUOROURACIL | 326 |
| 9 | FLUOROURACIL CREAM, 0.5% | 325 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIENTINE HYDROCHLORIDE | 9 | 0.0489 |
| 1 | DAUNORUBICIN HYDROCHLORIDE | 46 | 0.0279 |
| 2 | PEGASPARGASE | 143 | 0.0116 |
| 3 | MERCAPTOPURINE | 173 | 0.0099 |
| 4 | FLURAZEPAM HYDROCHLORIDE | 4 | 0.0099 |
| 5 | CALCIUM FOLINATE | 42 | 0.0089 |
| 6 | NITAZOXANIDE | 3 | 0.0086 |
| 7 | NERATINIB | 18 | 0.0078 |
| 8 | CARMUSTINE | 31 | 0.0066 |
| 9 | ETRASIMOD | 11 | 0.0065 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1250 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 1061 |
| 2 | Platinum-based Drug [EPC] | 761 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 533 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 447 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 445 |
| 6 | Alkylating Drug [EPC] | 376 |
| 7 | Proton Pump Inhibitor [EPC] | 339 |
| 8 | Benzodiazepine [EPC] | 278 |
| 9 | Topoisomerase Inhibitor [EPC] | 257 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Asparagine-specific Enzyme [EPC] | 144 | 0.0107 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 1061 | 0.0039 |
| 2 | Somatostatin Analog [EPC] | 24 | 0.0035 |
| 3 | Topoisomerase Inhibitor [EPC] | 257 | 0.0033 |
| 4 | CTLA-4-directed Blocking Antibody [EPC] | 158 | 0.0033 |
| 5 | Bile Acid Sequestrant [EPC] | 36 | 0.0029 |
| 6 | Platinum-based Drug [EPC] | 761 | 0.0028 |
| 7 | Rifamycin Antimycobacterial [EPC] | 9 | 0.0026 |
| 8 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 21 | 0.0024 |
| 9 | Phenothiazine [EPC] | 72 | 0.0024 |